Please assess the completion status of the following clinical trial:

Trial Title: Study of the Efficacy of PedyPhar® Ointment on the Diabetic Foot Ulcers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult diabetic foot syndrome subjects over 18 years of age of any sex~* All stages of diabetic foot syndrome including Wagner stage 5 - Mid-foot gangrene only after appropriate surgical treatment.~* Patients suffering from type 1 or type 2 diabetes mellitus with diabetic foot syndrome.~* Stable metabolic and pharmacological control at recruitment and during the trial period.~* Adequate perfusion of lower limb as measured by HHD and confirmed by APSV.~Exclusion Criteria:~* Non-diabetic foot ulceration (traumatic, thermal ulceration etc)~* Diabetic foot syndrome graded 5 on Wagner's scale - hind foot gangrene only.~* Any pathological state or disease which can affect the development and outcomes of diabetic foot syndrome such as liver cell failure and renal failure~* Severe limb ischemia (by clinical assessment and HHD) unless re-vascularized.~* Presence of slough or sequestrum unless debrided.~* Hemoglobin less than 8 g/dl unless corrected.~* Those receiving NSAIDs, steroids or anti-mitotic drugs.~* Septicemia patients requiring urgent amputation.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Pedyphar (Type: EXPERIMENTAL): Ointment
- Panthenol (Type: ACTIVE_COMPARATOR): Ointment

Based on this trial design, predict the completion outcome and termination type (if applicable).